Evidence map›Paper›PMID 34022129›Full record

ArticleCell stem cell2021

SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium.

Anne Z Eriksen, Rasmus Møller, Bar Makovoz, Skyler A Uhl, Benjamin R tenOever, Timothy A Blenkinsop

Abstract read
In one paragraph

Article in Cell stem cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. A survey of SARS-CoV-2 tropism.Infectious diseases & immunity · 2025
    Review
  5. Organoids: physiologically relevantJournal of virology · 2025
    Review
  6. Article
  7. Recent Advances in Stem Cells of Corneal Epithelia.Investigative ophthalmology & visual science · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Anne Z EriksenDepartment of Cell Development and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby 2800, Denmark.
Rasmus MøllerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Bar MakovozDepartment of Cell Development and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Skyler A UhlDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Benjamin R tenOeverDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: benjamin.tenoever@mssm.edu.
Timothy A BlenkinsopDepartment of Cell Development and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: timothy.blenkinsop@mssm.edu.

Funding

Reversing Contractility in Epiretinal MembranesR01EY029736 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BLENKINSOP, TIMOTHY A. · 2020 to 2024
$2.0M
Stemness and the cellular response to virus infectionR21AI132913 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TENOEVER, BENJAMIN R. · 2018 to 2019
$480k
Transcriptional regulators of iris muscle cell developmentR21EY030215 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BLENKINSOP, TIMOTHY A. · 2020 to 2021
$457k
NEI NIH HHS R01 EY029736NEI NIH HHS R21 EY030215NIAID NIH HHS R21 AI132913
6 · The paper itself

Abstract

The SARS-CoV-2 pandemic has caused unparalleled disruption of global behavior and significant loss of life. To minimize SARS-CoV-2 spread, understanding the mechanisms of infection from all possible routes of entry is essential. While aerosol transmission is thought to be the primary route of spread, viral particles have been detected in ocular fluid, suggesting that the eye may be a vulnerable point of viral entry. To this end, we confirmed SARS-CoV-2 entry factor and antigen expression in post-mortem COVID-19 patient ocular surface tissue and observed productive viral replication in cadaver samples and eye organoid cultures, most notably in limbal regions. Transcriptional analysis of ex vivo infected ocular surface cells and hESC-derived eye cultures revealed robust induction of NF-κB in infected cells as well as diminished type I/III interferon signaling. Together these data suggest that the eye can be directly infected by SARS-CoV-2 and implicate limbus as a portal for viral entry.

Indexed as

COVID-19Human Embryonic Stem CellsAdultEpitheliumHumansPandemicsSARS-CoV-2ACE2corneaCOVID-19eyeinterferonlimbusNF-κBSARS-CoV-2scRNA-seqstem cells

Identifiers

PMID34022129
PMCPMC8126605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.